Home

As Detective Ontslag rituximab dose rheumatoid arthritis mat Gewend aan PapoeaNieuwGuinea

RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis

European Medicines Agency approved rituximab dosing regimens [ 10 ] . |  Download Table
European Medicines Agency approved rituximab dosing regimens [ 10 ] . | Download Table

Discontinuation and dose reduction of rituximab in relapsing–remitting  multiple sclerosis | SpringerLink
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis | SpringerLink

Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based  biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine

Arthritis News: Lower Dose of Rituximab for RA Treatment Explored
Arthritis News: Lower Dose of Rituximab for RA Treatment Explored

PV | Taking & Dosing RITUXAN® (rituximab)
PV | Taking & Dosing RITUXAN® (rituximab)

PV | RITUXAN® (rituximab) Dosing & Infusion Resources
PV | RITUXAN® (rituximab) Dosing & Infusion Resources

RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis

Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis  (REDO study): a randomised controlled non-inferiority trial - The Lancet  Rheumatology
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial - The Lancet Rheumatology

Drug Insight: the mechanism of action of rituximab in autoimmune  disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology

Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis - MPR
Rituximab Biosimilar Truxima Now Available for Rheumatoid Arthritis - MPR

Rheumatoid arthritis patients initiating rituximab with low number of  previous bDMARDs failures may effectively reduce rituximab dose and  experience fewer serious adverse events than patients on full dose: a  5-year cohort study
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study

Algorithm for the use of rituximab in patients with RA. Broken line... |  Download Scientific Diagram
Algorithm for the use of rituximab in patients with RA. Broken line... | Download Scientific Diagram

RA | RITUXAN® (rituximab) Infusion Steps & Resources
RA | RITUXAN® (rituximab) Infusion Steps & Resources

Should You Get the COVID-19 Vaccine If You Take Rituximab?
Should You Get the COVID-19 Vaccine If You Take Rituximab?

VisualAbstract: Tocilizumab is superior to rituximab for treatment of rheumatoid  arthritis in patients with low or absent B-cell lineage expression | 2  Minute Medicine
VisualAbstract: Tocilizumab is superior to rituximab for treatment of rheumatoid arthritis in patients with low or absent B-cell lineage expression | 2 Minute Medicine

Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis -  Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online  Library
Anti‐CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis - Korhonen - 2010 - Basic & Clinical Pharmacology & Toxicology - Wiley Online Library

Ultra-Low Dose of Rituximab Safely Eases Rheumatoid Arthritis Over Long  Term: Study - Consumer Health News | HealthDay
Ultra-Low Dose of Rituximab Safely Eases Rheumatoid Arthritis Over Long Term: Study - Consumer Health News | HealthDay

JCM | Free Full-Text | Effectiveness of Different Rituximab Doses Combined  with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis:  Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical  Trial (AMARA)
JCM | Free Full-Text | Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)

GPA & MPA | Taking & Dosing RITUXAN® (rituximab)
GPA & MPA | Taking & Dosing RITUXAN® (rituximab)

Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis  of Different Regimens | HTML | Acta Dermato-Venereologica
Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens | HTML | Acta Dermato-Venereologica

Protocol of rituximab dosing and administration. | Download Scientific  Diagram
Protocol of rituximab dosing and administration. | Download Scientific Diagram

Rituximab protocols | Download Table
Rituximab protocols | Download Table

Treatment of rheumatoid arthritis with rituximab: An update and possible  indications - ScienceDirect
Treatment of rheumatoid arthritis with rituximab: An update and possible indications - ScienceDirect

Rituximab Infusion Dosing | RIABNI™ (rituximab-arrx)
Rituximab Infusion Dosing | RIABNI™ (rituximab-arrx)

Safety of infusing rituximab at a more rapid rate in patients with rheumatoid  arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders |  Full Text
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study | BMC Musculoskeletal Disorders | Full Text

Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning
Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning

Lessons for rituximab therapy in patients with rheumatoid arthritis - The  Lancet Rheumatology
Lessons for rituximab therapy in patients with rheumatoid arthritis - The Lancet Rheumatology

Efficacy and safety of different doses and retreatment of rituximab: a  randomised, placebo-controlled trial in patients who are biological naïve  with active rheumatoid arthritis and an inadequate response to methotrexate  (Study Evaluating
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating